This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Just A Kid In The Car Absolutely Destroying 'Smooth Criminal' On His Ukulele
Two Cats Won't Give Up On Trying To Enter A Museum
Physicist Wins Ig Noble Prize For Study On Whether Cats Should Be Classified As Liquids Or Solids
This Weird Looking Cat Is Creeping People Out, But We Think He's Adorable
Read What The Jewish Nurse Wrote After Caring For The Pittsburgh Synagogue Shooter
Meet Maverick, The Trucker Cat Who Travels The US With His Sidekick Goose
Mom Can't Turn Away For A Second
Two West Virginia Fans Stole The Show At Football Game
Mailman Drops Off Package, Then Waits Patiently For His Friends
Bald Eagle Couple Gets Into Argument While Assembling Nest
Brian May Tears Up While Singing 'Love Of My Life' With The Crowd In Amsterdam